Vasella wins chairman role at Alcon

Novartis Chairman Daniel Vasella (photo) was elected to the additional position of board chairman of Alcon, a move that further asserts Novartis's control of the eye-care company as it seeks to buy the 23 percent it doesn't already own. Report